Sandoz wins Canada nod for generic Ozempic; inks licensing deal for generic Hemlibra

RegulatoryapprovedOzempicHemlibraPositive

AI Analysis

Summary

Sandoz received Canadian regulatory approval for a generic version of Ozempic and secured a licensing agreement for a generic Hemlibra, expanding its generic drug portfolio in the Canadian market.

Outcome Details

Sandoz wins Canadian approval for generic Ozempic and inks licensing deal for generic Hemlibra

Importance:6/10

Sentiment:

0.70

genericCanadaregulatory approvallicensing deal

Related Companies

$SDZ.SW

Read the original article

Published by Seeking Alpha Healthcare on September 18, 2026 12:24 PM

Read Original